Interrelationships Between Sclerostin, Secondary Hyperparathyroidism, and Bone Metabolism in Patients on Hemodialysis.
Nakagawa Y, Komaba H, Hamano N, Tanaka H, Wada T, Ishida H, Nakamura M, Takahashi H, Takahashi Y, Hyodo T, Hida M, Suga T, Kakuta T, Fukagawa M.
Nakagawa Y, et al. Among authors: wada t.
J Clin Endocrinol Metab. 2022 Jan 1;107(1):e95-e105. doi: 10.1210/clinem/dgab623.
J Clin Endocrinol Metab. 2022.
PMID: 34423837